Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL809377 | 0.67 | CA1 (0.38) | CA1CA2CA9 | |
| SCHEMBL5168578 | 0.67 | — | — | |
| SCHEMBL5350300 | 0.65 | CA1 (0.32) | CA1CA2CA9 | |
| SCHEMBL14814382 | 0.65 | — | — | |
| SCHEMBL9777745 | 0.65 | — | — | |
| SCHEMBL14814539 | 0.65 | — | — | |
| SCHEMBL6548087 | 0.64 | CA1 (0.36) | CA1CA2CA9 | |
| SCHEMBL9124188 | 0.64 | CA1 (0.36) | CA1CA2CA9 | |
| SCHEMBL23251429 | 0.62 | CA1 (0.31) | CA1CA2CA9 | |
| SCHEMBL3414999 | 0.62 | CA1 (0.31) | CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-4112862-B2 | — | — | 2008-07-02 | — | — | JP | claimed |
| EP-1268381-A4 | PRODUCTION OF FLUORMETHYL 2,2,2-TRIFLUORO-1-(TRIFLUOROMETHYL)ETHYL ETHER | HALOCARBON PROD CORP (US) | 2004-10-20 | — | — | EP | claimed |
| JP-2003530323-A | — | — | 2003-10-14 | — | — | JP | claimed |
| EP-1268381-A1 | PRODUCTION OF FLUORMETHYL 2,2,2-TRIFLUORO-1-(TRIFLUOROMETHYL)ETHYL ETHER | Halocarbon Products Corporation (US) | 2003-01-02 | — | — | EP | claimed |
| WO-2001068577-A1 | PRODUCTION OF FLUORMETHYL 2,2,2-TRIFLUORO-1-(TRIFLUOROMETHYL)ETHYL ETHER | HALOCARBON PRODUCTS CORPORATION (US) | 2001-09-20 | — | — | WO | claimed |
| US-11958971-B2 | Photocurable composition, method for producing concave-convex structure, method for forming fine concave-convex pattern, and concave-convex structure | MITSUI CHEMICALS, INC. (JP) | 2024-04-16 | — | — | US | disclosed |
| US-20230348438-A1 | PYRAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF | JAPAN TOBACCO INC. (JP) | 2023-11-02 | — | — | US | disclosed |
| WO-2023189217-A1 | METHOD FOR PRODUCING FLUORINE-CONTAINING CYCLIC OLEFIN COMPOSITION, AND FLUORINE-CONTAINING CYCLIC OLEFIN COMPOSITION | 三井化学株式会社 | 2023-10-05 | — | — | WO | disclosed |
| US-11597910-B2 | Medical instrument, cell culture method, fluorine-containing cyclic olefin polymer and fluorine-containing cyclic olefin polymer composition for it, and cultured cells | MITSUI CHEMICALS, INC. (JP) | 2023-03-07 | — | — | US | disclosed |
| EP-3998298-A1 | PHOTOCURABLE COMPOSITION, PRODUCTION METHOD FOR UNEVEN STRUCTURAL BODY, METHOD FOR FORMING MINUTE UNEVEN PATTERN, AND UNEVEN STRUCTURAL BODY | Mitsui Chemicals, Inc. (JP) | 2022-05-18 | — | — | EP | disclosed |
| US-20220135787-A1 | PHOTOCURABLE COMPOSITION, METHOD FOR PRODUCING CONCAVE-CONVEX STRUCTURE, METHOD FOR FORMING FINE CONCAVE-CONVEX PATTERN, AND CONCAVE-CONVEX STRUCTURE | MITSUI CHEMICALS, INC. (JP) | 2022-05-05 | — | — | US | disclosed |
| CN-113574086-A | Photocurable composition, method for producing uneven structure, method for forming fine uneven pattern, and uneven structure | 三井化学株式会社 | 2021-10-29 | — | — | CN | disclosed |
| US-7129014-B2 | Positive resist composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2006-10-31 | — | — | US | disclosed |
| US-6893792-B2 | Positive resist composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2005-05-17 | — | — | US | disclosed |
| US-20040224251-A1 | Positive resist composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2004-11-11 | — | — | US | disclosed |
| EP-1268381-A4 | PRODUCTION OF FLUORMETHYL 2,2,2-TRIFLUORO-1-(TRIFLUOROMETHYL)ETHYL ETHER | HALOCARBON PROD CORP (US) | 2004-10-20 | — | — | EP | disclosed |
| US-20030236351-A1 | Positive resist composition | SUMITOMO CHEMICAL COMPANY, LIMITIED (JP) | 2003-12-25 | — | — | US | disclosed |
| US-20030194639-A1 | Positive resist composition | FORTINET, INC. | 2003-10-16 | — | — | US | disclosed |
| EP-1268381-A1 | PRODUCTION OF FLUORMETHYL 2,2,2-TRIFLUORO-1-(TRIFLUOROMETHYL)ETHYL ETHER | Halocarbon Products Corporation (US) | 2003-01-02 | — | — | EP | disclosed |
| WO-2001068577-A1 | PRODUCTION OF FLUORMETHYL 2,2,2-TRIFLUORO-1-(TRIFLUOROMETHYL)ETHYL ETHER | HALOCARBON PRODUCTS CORPORATION (US) | 2001-09-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230348438-A1 | PYRAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF | CYP2C19, CYP3A7, CYP3A5 | CA1 4140/4885CA2 1930/4885CA9 1113/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.